Next Article in Journal
Detection, Quantification, and Microlocalisation of Targets of Pesticides Using Microchannel Plate Autoradiographic Imagers
Next Article in Special Issue
Polar Compounds Isolated from the Leaves of Albertisia delagoensis (Menispermaceae)
Previous Article in Journal
Antibacterial Characteristics and Activity of Water-Soluble Chitosan Derivatives Prepared by the Maillard Reaction
Previous Article in Special Issue
The Potential of Tetrandrine as a Protective Agent for Ischemic Stroke
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 16
Issue 10
10.3390/molecules16108515
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Anti-Inflammatory Activity of Alkaloids: An Update from 2000 to 2010

by
Augusto Lopes Souto
1,
Josean Fechine Tavares
1,
Marcelo Sobral Da Silva
1,
Margareth de Fátima Formiga Melo Diniz
1,
Petrônio Filgueiras De Athayde-Filho
2 and
José Maria Barbosa Filho
1,*
1
Laboratory of Pharmaceutical Technology, Federal University of Paraiba, 58051-900, João Pessoa-PB, Brazil
2
Department of Chemistry, Federal University of Paraíba, 58059-900, João Pessoa-PB, Brazil
*
Author to whom correspondence should be addressed.
Molecules 2011, 16(10), 8515-8534; https://doi.org/10.3390/molecules16108515
Submission received: 22 July 2011 / Revised: 7 September 2011 / Accepted: 26 September 2011 / Published: 11 October 2011
(This article belongs to the Special Issue Alkaloids: Novel Therapeutic Perspectives)
Versions Notes

Abstract

:
Many natural substances with proven anti-inflammatory activity have been isolated throughout the years. The aim of this review is to review naturally sourced alkaloids with anti-inflammatory effects reported from 2000 to 2010. The assays were conducted mostly in vivo, and carrageenan-induced pedal edema was the most used experimental model. Of the 49 alkaloids evaluated, 40 demonstrated anti-inflammatory activity. Of these the most studied type were the isoquinolines. This review was based on NAPRALERT data bank, Web of Science and Chemical Abstracts. In this review, 95 references are cited.

1. Introduction

Inflammation has been studied for thousands of years. Celsius (in 30 A.D.) described the four classical signs of inflammation (redness, heat, pain, and swelling), and used willow leaf extracts to relieve them [1].
The inflammatory process is a reaction of the body to the penetration of an infectious agent, an antigen, or cell damage. Inflammation is the most frequent sign of disease, and is also a fundamental biological process involving complex pathways that are often induced by the products of bacterial degradation from various microorganisms; lipopeptides, lipopolysaccharides, peptidoglycans, formylmethionyl peptides, flagellin, microbial DNA), fungi (zymosans), viruses (double-stranded RNA), or even the body’s own cells upon damage and death [2].
The inflammatory response starts with signal recognition that may have an infectious or inflammatory origin, and the release of chemicals from tissues and migrating cells called mediators [3]. The list of these mediators includes amines like histamine and 5-hydroxytryptamine, bradykinin, (representing short peptides), long peptides such as interleukin-1 (IL-1), lipids such as prostaglandins (PGs) and leukotrienes (LTs), and enzymes [1]. During the immune response, these mediators recruit adjacent cells through the paracrinal process. When these mediators exceed local borders, they disseminate, and distribute through the blood, producing endocrinal generalized cellular activation, or systematic inflammatory response syndrome (SIRS). SIRS is a host defense mechanism, and part of the tissue repair process. To effectively initiate this defense mechanism, cytokines with pro-inflammatory function are required, such as TNF-α, IL-1β, interleukin-12 (IL-12), interferon-γ (IFN-γ) and possibly IL-6 [4,5,6,7]. The initial inflammatory response is controlled by immune-regulating molecules through specific inhibitors, and soluble cytokine receptors. The main anti-inflammatory cytokines are transforming beta growth factor (TGF-β) and interleukins 4 and 10. Specific receptors for IL-1, TNF-α and interleukin-18 (IL-18) act as inhibitors of their own pro-inflammatory cytokines. Under physiological conditions immune-modulator molecules act to limit the potentially harmful effects of the inflammatory response [3]. The importance of each of these mediators can be seen when it is removed (either by preventing its generation with enzyme inhibitors or by preventing its pharmacological effects with selective antagonists) [1].
In inflammation research, several experimental models have been used to evaluate inflammation. The usual method of determining whether compounds have anti-inflammatory activity is to test them in animal, and biochemical inflammation models. However there is no single experimental model that covers all aspects of inflammation.
Natural products have long been recognized as an important source of therapeutically effective medicines. It is recognized that natural-product structures have great chemical diversity, biochemical specificity, and other molecular properties that make them favorable lead structures [8,9,10,11,12,13].
Among the 877 small-molecules New Chemical Entities (NCEs) introduced between 1981 and 2002, roughly 49% (~429 molecules) were natural products, semi-synthetic natural product analogues, or synthetic compounds based on natural-products [9], moreover, between 2005 and 2007, 13 natural, product-derived drugs were approved in the United States, with five of them being the first members of new classes [14]. In recent years advances in chemical and pharmacological techniques have contributed to the knowledge of new therapeutically active compounds obtained from natural products [15].
The alkaloids represent the largest single class of plant secondary metabolites. They have a remarkable range of often dramatic pharmacological activity, and are also often toxic to man [16]. Many alkaloids are used in therapeutics and as pharmacological tools. A wide range of biological effects has been reported for alkaloids, including emetic, anti-cholinergic, antitumor, diuretic, sympatho-mimetic, antiviral, antihypertensive, hypno-analgesic, antidepressant, mio-relaxant, anti-tussigen, antimicrobial and anti-inflammatory activities [17,18,19]. However, alkaloids and other natural compounds are generally complex, making it necessary to analyze their pharmacological activities using several experimental methods and demonstrate their structure/activity correlation. It is common to find pharmacological data where a single experimental model was used to demonstrate a biological activity. However pathological responses are extremely complex involving many biological events, so it is necessary to use different experimental models to define the exactly mechanism of action of the analyzed molecule [20].
In the course of our continuing search for bioactive natural plant products, we have published reviews on crude plant extracts and plant-derived compounds with potential uses [21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. Moreover, our group has also reviewed the medicinal and poisonous plants of Northeast Brazil [38,39], among others [40,41,42,43,44,45,46,47,48,49,50,51,52]. Recently we published a review on the anti-inflammatory activity of alkaloids reported in the twentieth century, more precisely covering the period from 1907 to 2000 [53]. Now we present an update of the literature on alkaloids with anti-inflammatory activity from 2000 to 2010. The search was carried out on data banks such as Web of Science, Chemical Abstracts, and NAPRALERT (acronym for the University of Illinois Natural Products ALERT service). The references found in the searches were later consulted. For details on the mechanism-based bioassays utilized for anti-inflammatory activity, the original references should be consulted.

2. Results and Discussion

Isoquinoline, quinoline and indole alkaloids were the most studied classes for anti-inflammatory activity. Among the isoquinolines, berberine was the most studied compound, being active in almost all the experimental models described in Table 1. This compound is present in numerous plants of the Berberis and Coptis genera [54]. It is one of the major components of Coptis chinesis, which is frequently utilized in Chinese herbal drugs to treat inflammatory reactions. Berberine has a variety of pharmacologic effects, including inhibition of TPA-induced mouse ear edema, indicating that this alkaloid may have activity against chronic inflammation [55].
Investigations demonstrated that warifteine, a bisbenzylisoquinoline alkaloid isolated from Cissampelos sympodialis, inhibits eosinophil recruitment, eotaxin and cisteinyl leukotriene production in the pleural cavities, and lungs of allergic mice, as well as inhibiting in the production of nitric oxide mediators. These data highlight the role of warifteine as a potential anti-allergic and anti-inflammatory molecule [56,57]. Other isoquinoline alkaloids like berbamine, palmatine and columbamine were also examined demonstrating significant dose-dependent inhibitory activity in serotonin-induced hind paw edema assays for both oral and topical applications, and in oral administration, on acetic acid-induced vascular permeability [58].
The quinolizidine alkaloids matrine and oxymatrine, isolated from Sophora subprostrata (a Chinese plant used as an antipyretic, antidote, and analgesic) exhibited in vitro cyclooxygenase inhibition and antioxidant activity, providing scientific support for their existing medicinal use in traditional Chinese medicine [59].
Indole alkaloids such as brucine and brucine-N-oxide were also reported in this review. They demonstrated significant analgesic and anti-inflammatory properties. Both compounds demonstrated a substantial protective effect in experimental models such as hot-plate test and writhing test. Although, in formalin test, they exhibited their analgesic activity in different phases. In carrageenan-induced rat paw edema experiment, brucine N-oxide showed stronger inhibitory effect than brucine. In addition, these two substances have diminished acetic-acid induced vascular permeability and inhibited the release of PGE2 in inflammatory tissue. These results suggest that brucine and brucine-N-oxide have different biochemical mechanisms, in spite of having similar chemical structure [60].
Marine natural products have been the focus for discovery of new chemical and pharmacological products. A bisindolic alkaloid named caulerpin isolated from the lipoid extract of the algae Caulerpa racemosa exhibited anti-inflammatory activity in mice when given orally at a concentration of 100 μmol/kg [63]. The bisindolic pharmacophoric nucleus of caulerpin is most likely responsible for the wide variety of biological properties tested; anti-inflammatory, antinociceptive [61] insecticidal [62], tumor inhibition [63], and inhibition of hypoxia transcription factor [64], all for this one alkaloid.
Amide alkaloids such as riparin I (N-benzoyl tyramine) and II (N-(2-hydroxybenzoyl) tyramine), isolated from the unripe fruit of Aniba riparia decreased carrageenan-induced paw edema at 4 h and 2 h respectively, when compared to a control [65,66]. It appears that the degree of hydroxylation of the benzoyl moiety increases the anti-inflammatory activity.
Most of the alkaloids reported in this review offer considerable promise as anti-inflammatory compounds or drug candidates and some of them appear to be remarkably active. The results of this search are presented in Table 1 in alphabetical order of their chemical names, followed by the plant species of origin. The references were consulted for details of the experimental models used while testing the alkaloid’s anti-inflammation activities (assay, organism tested, dose or concentration, activity, and references).
Table
Table 1. Alkaloids with anti-inflammatory activity.
Table 1. Alkaloids with anti-inflammatory activity.
Substance and (Source)AssayOrganism testedDoseActivityRef.
Molecules 16 08515 i001In vivo, 5-HT-Induced pedal edemaMouse200 mg/KgInactive[58]
In vivo, 5-HT-Induced pedal edemaMouse200 mg/KgActive[58]
Molecules 16 08515 i002In vivo, inhibitory activity on superoxide generation by human neutrophilsHumanIC50 ≤ 5.34 µg/mLActive[67]
In vivo, inhibitory activity on elastase release by human neutrophilsHumanIC50 ≤ 5.53 µg/mLActive[67]
Molecules 16 08515 i003In vivo, carrageenan-induced pedal edemaRat1 mg/KgActive[68]
Molecules 16 08515 i004In vivo, inhibitory activity on superoxide generation by human neutrophilsHumanIC50 ≤ 5.34 µg/mLActive[67]
Molecules 16 08515 i005In vivo, 5-HT-induced pedal edemaMouse200 mg/KgActive[58]
In vivo, 5-HT-induced pedal edemaMouse100 mg/KgActive[58]
In vivo, TNB-induced colitisRat15 mg/KgActive[69]
Molecules 16 08515 i006In vivo, LPS-induced hepatoxicityMouse100 mg/KgInactive[70]
In vivo, carrageenan-induced pedal edemaMouse2 mg/KgActive[70]
In vivo, LPS-induced hepatoxicityMouse209 mg/KgActive[70]
In vivo, 5-HT induced-pedal edemaMouse200 mg/KgActive[58]
In vivo, Carrageenan-induced pedal edemaRat5 mg/KgActive[55]
In vivo, acute inflammation induced by E. coli LPSChicken15 mg/KgActive[71]
Molecules 16 08515 i007In vivo, carrageenan-induced pedal edemaRat15 mg/KgActive[60]
Molecules 16 08515 i008In vivo, carrageenan-induced pedal edemaRat100 mg/KgActive[60]
Molecules 16 08515 i009In vivo, capsaicin-induced ear edemaMouse100 µmol/KgActive[61]
Molecules 16 08515 i010In humans, oralHuman adult0.5 mg/personActive[72]
Molecules 16 08515 i011In vivo, External, 5-HT-induced pedal edemaMouse200 mg/KgInactive[58]
In vivo, Intragastric, 5-HT-induced pedal edemaMouse200 mg/KgInactive[58]
Molecules 16 08515 i012In vivo, inhibitory activity on superoxide generation by human neutrophilsHumanIC50 ≤ 5.34 µg/mLActive[67]
In vivo, inhibitory activity on elastase release by human neutrophilsHumanIC50 ≤ 5.53 µg/mLActive[67]
Molecules 16 08515 i013In vivo, carrageenan-induced paw edemaRat10 mg/KgActive[73]
Molecules 16 08515 i014In vivo, carrageenan-induced rat paw edemaRat20 mg/KgActive[74]
Molecules 16 08515 i015In vivo, croton oil-induced edemaMouse20 mg/KgActive[75]
In vivo, croton oil-induced edemaMouse0.1 mg/KgActive[75]
In vitro, fMLP-induced neutrophil adhesion and transmigrationHuman10 µg/mLActive[76]
Molecules 16 08515 i016In vivo, croton oil-induced ear edemaMouse4.2 ± 0.5 mg/KgActive[77]
Molecules 16 08515 i017In vivo, croton oil-induced ear edemaMouse3.7 ± 0.8 mg/KgActive[77]
Molecules 16 08515 i018In vitro, inhibitory activity on superoxide anion generationHumanIC50 < 5.5 5.43±1.52µg/mLActive[78]
In vitro, inhibitory activity on elastase release by human neutrophilsHumanIC50 < 5.5 3.25 ± 0.31 µg/mLActive[78]
Molecules 16 08515 i019In vivo, carrageenan-induced pedal edemaMouse1 mg/KgActive[79]
Molecules 16 08515 i020In vivo, carrageenan-induced pedal edemaMouse1 mg/KgActive[79]
Molecules 16 08515 i021***Inactive[80]
Molecules 16 08515 i022In vitro, macrophagesHuman adult400 mg/LActive[81]
In vivo, carrageenan-induced pedal edemaRat50 mg/KgActive[82]
In vivo, Cotton pellet granulomaMouse50 mg/KgActive[82]
Molecules 16 08515 i023In vivo, 5-HT-induced pedal edemaMouse200 mg/KgInactive[58]
In vivo, 5-HT-induced pedal edemaMouse200 mg/KgInactive[58]
Molecules 16 08515 i024***Inactive[80]
Molecules 16 08515 i025***Inactive[80]
Molecules 16 08515 i026In vitro, inhibitory activity of COX-1 Rat31.3 µMActive[59]
In vitro, inhibitory activity of COX-2Rat188.5 µMModerate activity[59]
Molecules 16 08515 i027In vitro, inhibitory activity of COX-1 Rat197.8 µMModerate activity [59]
In vitro, inhibitory activity of COX-2Rat385.1 µMWeak activity[59]
Molecules 16 08515 i028In vivo, collagen II -induced arthritisMouse10 mg/KgActive[83]
Molecules 16 08515 i029In vivo, 5-HT-induced pedal edemaMouse200 mg/KgInactive[58]
In vivo, 5-HT-induced pedal edemaMouse100 mg/KgActive[58]
Molecules 16 08515 i030In vitro, inhibitory activity on NO production Rat40 µg/mLActive[84]
In vitro, inhibitory activity on PGE2 production Rat40 µg/mLActive[84]
Molecules 16 08515 i031In vitro, inhibitory activity on COX-1 *100 µMInactive[85]
In vitro, inhibitory activity on COX-2 *100 µMWeak activity[85]
In vitro, inhibitory activity on 5-LOX *100 µMActive[85]
In vivo, carrageenan-induced air pouch formationMouse10 mg/KgActive[85]
In vivo, xylene-induced ear edemaMouse10 mg/KgActive[85]
Molecules 16 08515 i032In vivo, intragastricRat20 mg/KgActive[86]
Molecules 16 08515 i033In humans, oralHuman adult200 mg/dayInactive[87]
Molecules 16 08515 i034In vivo, formalin testMice25 mg/KgActive[88]
In vivo, carrageenan-induced pedal edemaMice25 mg/KgActive[65]
Molecules 16 08515 i035In vivo, carrageenan-induced pedal edemaRat25 mg/KgActive[66]
Molecules 16 08515 i036In vitro, inhibitory activity on COX-1 Mice100 µMActive[85]
In vitro, inhibitory activity on COX-2 Mice100 µMActive [85]
In vitro, inhibitory activity on 5-LOX Mice100 µMActive[85]
In vivo, carrageenan-induced air pouch formationMouse5 mg/KgActive[85]
In vivo, xylene-induced ear edemaMouse5 mg/KgActive[85]
Molecules 16 08515 i037In vitro, phorbol-induced edema of the mouse earMouse5–100 µg/earActive[89]
Molecules 16 08515 i038In vivo, collagen II induced arthritisRat3.036 mg/KgActive[90]
Molecules 16 08515 i039In vivo, TPA-induced inflammationMouse0.75 mg/earActive[91]
Molecules 16 08515 i040In vivo, carrageenan-induced pedal edemaRat*Inactive[92]
In vivo, cotton pellet granulomaRat*Inactive[92]
Molecules 16 08515 i041In vitro, colorimetric assay with tetrazolium saltBlood drawn from healthy volunteers100 µg/mLWeak Activity[93]
Molecules 16 08515 i042In vivo, croton oil-induced edemaMouse20 mg/KgActive[75]
In vivo, croton oil-induced edemaMouse0.1 mg/KgActive[75]
In vitro, FMLP-induced neutrophil adhesion and transmigrationHuman10 µg/mLActive[76]
Molecules 16 08515 i043In vivo, xylene-induced ear edemaMouse8 mg/KgActive[94]
In vivo, acetic acid-induced vascular permeabilityMouse16 mg/KgActive[94]
In vivo, carrageenan-induced paw edemaMouse8 mg/KgActive[94]
Molecules 16 08515 i044In vitro, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay systemHumanIC50 = 27.3 µg/mLWeak activity[95]
Molecules 16 08515 i045In vitro, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay systemHumanIC50 = 48.3 µg/mLWeak activity[95]
Molecules 16 08515 i046In vitro, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay systemHumanIC50 = 4.21 µg/mLActive[95]
Molecules 16 08515 i047In vitro, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay systemHumanIC50 = 79.1 µg/mLWeak activity[95]
Molecules 16 08515 i048In vitro, inhibitory activity on COX-1 Mice100 µMActive[85]
In vitro, inhibitory activity on COX-2 Mice100 µMActive[85]
In vitro, inhibitory activity on 5-LOX Mice100 µMActive[85]
In vivo, carrageenan-induced air pouch formationMouse8 mg/KgActive[85]
In vivo, xylene-induced ear edemaMouse8 mg/KgActive[85]
Molecules 16 08515 i049In vivo, allergic eosinophilia and cysteinyl leukotrienes productionMice50 μg/animalActive[56]
In vitro. OVA-sensitized animals were evaluated. The response was related with the increase of NO productionMice0.4–10 mg/KgActive[57]
* Data incomplete, derived from an abstract.

3. Conclusions

Of the 49 alkaloids evaluated, 40, among which the isoquinolines figured most prominently, demonstrated anti-inflammatory activity. Carrageenan-induced pedal edema was the most utilized experimental model for evaluating anti-inflammatory activity. In this review, 95 references were cited.

Acknowledgements

The authors wish to express their sincere thanks to professors Márcia Regina Piuvezam, Leônia Maria Batista, Luis Cezar Rodrigues, and Bárbara Viviana de Oliveira Santos for their useful suggestions, as well as to the College of Pharmacy of the University of Illinois at Chicago, Chicago, IL, USA, for aiding with the NAPRALERT computer search of anti-inflammatory activity. Thanks are also thankful for the financial support provided by CNPq/CAPES and PRONEX/FAPESQ, Brazil.
  • Sample Availability: Samples of the compounds are not available from the authors.

References

  1. Vane, J.; Botting, R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J. 1987, 1, 89–96. [Google Scholar]
  2. Kulinsky, V.I. Biochemical aspects of inflammation. Biochemistry 2007, 72, 733–746. [Google Scholar]
  3. Blancas-Flores, G.; Almanza-Pérez, J.C.; López-Roa, R.I.; Alarcón-Aguilar, F.J.; García-Macedo, R.; Cruz, M. Obesity as an inflammatory process. Bol. Med. Hosp. Infant. Mex. 2010, 67, 88–96. [Google Scholar]
  4. Kim, S.; Choi, M.G.; Lee, H.S.; Lee, S.K.; Kim, S.H.; Kim, W.W.; Hur, S.M.; Kim, J.H.; Choe, J.H.; Nam, S.J.; et al. Silibinin suppresses TNF-α-induced MMP-9 expression in gastric cancer cells through Inhibition of the MAPK pathway. Molecules 2009, 14, 4300–4311. [Google Scholar] [CrossRef]
  5. Lee, D.C.W.; Lau, A.S.Y. Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review. Molecules 2011, 16, 2802–2816. [Google Scholar] [CrossRef] [Green Version]
  6. Chen, L.; He, T.; Han, Y.; Sheng, J.Z.; Jin, S.; Jin, M.W. Pentamethylquercetin improves adiponectin expression in differentiated 3T3-L1 cells via a mechanism that implicates PPARγ together with TNF-α and IL-6. Molecules 2011, 16, 5754–5768. [Google Scholar] [CrossRef]
  7. Qiao, Z.; Ma, J.; Liu, H. Effect of Ligusticum wallichii aqueous extract on oxidative injury and immunity activity in myocardial ischemic reperfusion rats. Int. J. Mol. Sci. 2011, 12, 1991–2006. [Google Scholar] [CrossRef]
  8. Ekstein, D.; Schachter, S.C. Natural products in epilepsy-the present situation and perspectives for the future. Pharmaceuticals 2010, 3, 1426–1445. [Google Scholar]
  9. Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nature 2005, 4, 206–220. [Google Scholar]
  10. McCloud, T.G. High throughput extraction of plant, marine and fungal specimens for preservation of biologically active molecules. Molecules 2010, 15, 4526–4563. [Google Scholar] [CrossRef]
  11. Scotti, L.; Ferreira, E.I.; Silva, M.S.; Scotti, M.T. Chemometric studies on natural products as potential inhibitors of the NADH. Molecules 2010, 15, 7363–7377. [Google Scholar] [CrossRef]
  12. Reis, F.S.; Pereira, E.; Barros, L.; Sousa, M.J.; Martins, A.; Ferreira, I.C.F.R. Biomolecule profiles in inedible wild mushrooms with antioxidant value. Molecules 2011, 16, 4328–4338. [Google Scholar] [CrossRef]
  13. Kong, K.W.; Khoo, H.E.; Prasad, K.N.; Ismail, A.; Tan, C.P.; Rajab, N.F. Revealing the power of the natural red pigment lycopene. Molecules 2010, 15, 959–987. [Google Scholar] [CrossRef]
  14. Li, J.W.H.; Vederas, J.C. Drug discovery and natural products: End of an era or an endless frontier? Science 2009, 325, 161–165. [Google Scholar] [CrossRef]
  15. Cechinel Filho, V.; Yunes, R.A. Estratégias para obtenção de compostos farmacologicamente ativos a partir de plantas medicinais: Conceitos sobre modificação estrutural para otimização da atividade. Quim. Nova 1998, 21, 99–105. [Google Scholar] [CrossRef]
  16. Talib, W.H.; Mahasneh, A.M. Antimicrobial, cytotoxicity and phytochemical screening of Jordanian plants used in traditional medicine. Molecules 2010, 15, 1811–1824. [Google Scholar] [CrossRef]
  17. Henriques, A.T.; Limberger, R.P.; Kerber, V.A.; Moreno, P.R.H. Alcalóides: Generalidades e Aspectos Básicos. In Farmacognosia: Da Planta Ao Medicamento, 5th; Simões, C.M.O., Schenkel, E.P., Gosmann, G., Mello, J.C.P., Mentz, L.A., Petrovick, P.R., Eds.; Editoras of the Universidades Federais de Santa Catarina and Rio Grande do Sul: Porto Alegre/Florianópolis, Brazil, 2004; pp. 765–792, Chapter 29. [Google Scholar]
  18. Ezell, S.J.; Li, H.; Xu, H.; Zhang, X.; Gurpinar, E.; Zhang, X.; Rayburn, E.R.; Sommers, C.I.; Yang, X.; Velu, S.E.; et al. Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent. Mar. Drugs 2010, 8, 2129–2141. [Google Scholar] [CrossRef]
  19. Aiello, A.; Fattorusso, E.; Imperatore, C.; Irace, C.; Luciano, P.; Menna, M.; Santamaria, R.; Vitalone, R. Zorrimidazolone, a bioactive alkaloid from the non-indigenous Mediterranean stolidobranch Polyandrocarpa zorritensis. Mar. Drugs 2011, 9, 1157–1165. [Google Scholar] [CrossRef] [Green Version]
  20. Falcão, H.S.; Leite, J.A.; Barbosa-Filho, J.M.; Athayde-Filho, P.F.; Chaves, M.C.O.; Moura, M.D.; Ferreira, A.L.; Almeida, A.B.A.; Souza-Brito, A.R.M.; Diniz, M.F.F.M.; et al. Gastric and duodenal antiulcer activity of alkaloids: A review. Molecules 2008, 13, 3198–3223. [Google Scholar] [CrossRef]
  21. Moura, M.D.; Torres, A.R.; Oliveira, R.A.G.; Diniz, M.F.F.M.; Barbosa-Filho, J.M. Natural products as inhibitors of models of mammary neoplasia. Br. J. Phytother. 2001, 5, 124–145. [Google Scholar]
  22. Moura, M.D.; Silva, J.S.; Oliveira, R.A.G.; Diniz, M.F.F.M.; Barbosa-Filho, J.M. Natural products reported as potential inhibitors of uterine cervical neoplasia. Acta Farm. Bonaer. 2002, 21, 67–74. [Google Scholar]
  23. Silva, J.S.; Moura, M.D.; Oliveira, R.A.G.; Diniz, M.F.F.M.; Barbosa-Filho, J.M. Natural product inhibitors of ovarian neoplasia. Phytomedicine 2003, 10, 221–232. [Google Scholar] [CrossRef]
  24. Gonçalves, M.C.R.; Moura, L.S.A.; Rabelo, L.A.; Barbosa-Filho, J.M.; Cruz, H.M.M.; Cruz, J. Natural products inhibitors of HMG CoA reductase. Rev. Bras. Farm. 2000, 81, 6371. [Google Scholar]
  25. Almeida, R.N.; Navarro, D.S.; Barbosa-Filho, J.M. Plants with central analgesic activity. Phytomedicine 2001, 8, 310–322. [Google Scholar] [CrossRef]
  26. Pereira, J.V.; Modesto-Filho, J.; Agra, M.F.; Barbosa-Filho, J.M. Plant and plant-derived compounds employed in prevention of the osteoporosis. Acta Farm. Bonaer. 2002, 21, 223–234. [Google Scholar]
  27. Morais, L.C.S.L.; Barbosa-Filho, J.M.; Almeida, R.N. Plants and bioactive compounds for the treatment of Parkinson’s disease. Arq. Bras. Fitomed.Cient. 2003, 1, 127–132. [Google Scholar]
  28. Rocha, L.G.; Almeida, J.R.G.S.; Macedo, R.O.; Barbosa-Filho, J.M. A review of natural products with antileishmanial activity. Phytomedicine 2005, 12, 514–535. [Google Scholar] [CrossRef]
  29. Barbosa-Filho, J.M.; Vasconcelos, T.H.C.; Alencar, A.A.; Batista, L.M.; Oliveira, R.A.G.; Guedes, D.N.; Falcão, H.S.; Moura, M.D.; Diniz, M.F.F.M.; Modesto-Filho, J. Plants and their active constituents from South, Central, and North America with hypoglycemic activity. Rev. Bras. Farmacogn. 2005, 15, 392–413. [Google Scholar] [CrossRef]
  30. Falcão, H.S.; Lima, I.O.; Santos, V.L.; Dantas, H.F.; Diniz, M.F.F.M.; Barbosa-Filho, J.M.; Batista, L.M. Review of the plants with anti-inflammatory activity studied in Brazil. Rev. Bras. Farmacogn. 2005, 15, 381–391. [Google Scholar] [CrossRef]
  31. Lima, G.R.M.; Montenegro, C.A.; Almeida, C.L.F.; Athayde-Filho, P.F.; Barbosa-Filho, J.M.; Batista, L.M. Database survey of anti-inflammatory plants in South America: A review. Int. J. Mol. Sci. 2011, 12, 2692–2749. [Google Scholar] [CrossRef]
  32. Barbosa-Filho, J.M.; Medeiros, K.C.P.; Diniz, M.F.F.M.; Batista, L.M.; Athayde-Filho, P.F.; Silva, M.S.; Cunha, E.V.L.; Almeida, J.R.G.S.; Quintans-Júnior, L.J. Natural products inhibitors of the enzyme acetylcholinesterase. Rev. Bras. Farmacogn. 2006, 16, 258–285. [Google Scholar] [CrossRef]
  33. Barbosa-Filho, J.M.; Martins, V.K.M.; Rabelo, L.A.; Moura, M.D.; Silva, M.S.; Cunha, E.V.L.; Souza, M.F.V.; Almeida, R.N.; Medeiros, I.A. Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980-2000. Rev. Bras. Farmacogn. 2006, 16, 421–446. [Google Scholar] [CrossRef]
  34. Amaral, F.M.M.; Ribeiro, M.N.S.; Barbosa-Filho, J.M.; Reis, A.S.; Nascimento, F.R.F.; Macedo, R.O. Plants and chemical constituents with giardicidal activity. Rev. Bras. Farmacogn. 2006, 16, 696–720. [Google Scholar] [CrossRef]
  35. Barbosa-Filho, J.M.; Nascimento-Júnior, F.A.; Tomaz, A.C.A.; Athayde-Filho, P.F.; Silva, M.S.; Cunha, E.V.L. Natural products with antileprotic activity. Rev. Bras. Farmacogn. 2007, 17, 141–148. [Google Scholar] [CrossRef]
  36. Falcão, H.S.; Mariath, I.R.; Diniz, M.F.F.M.; Batista, L.M.; Barbosa-Filho, J.M. Plants of the American continent with antiulcer activity. Phytomedicine 2008, 15, 132–146. [Google Scholar] [CrossRef]
  37. Mota, K.S.L.; Dias, G.E.N.; Pinto, M.E.F.; Luiz-Ferreira, A.; Souza-Brito, A.R.M.; Hiruma-Lima, C.A.; Barbosa-Filho, J.M.; Batista, L.M. Flavonoids with gastroprotective activity. Molecules 2009, 14, 979–1012. [Google Scholar]
  38. Agra, M.F.; França, P.F.; Barbosa-Filho, J.M. Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil. Rev. Bras Farmacogn. 2007, 17, 114–140. [Google Scholar] [CrossRef]
  39. Agra, M.F.; Silva, K.N.; Basílio, I.J.L.D.; França, P.F.; Barbosa-Filho, J.M. Survey of medicinal plants used in the region Northeast of Brazil. Rev. Bras Farmacogn. 2008, 18, 472–508. [Google Scholar] [CrossRef]
  40. Silva, F.L.; Fischer, D.C.H.; Tavares, J.F.; Silva, M.S.; Athayde-Filho, P.F.; Barbosa-Filho, J.M. Compilation of secondary metabolites from Bidens pilosa L. Molecules 2011, 16, 1070–1102. [Google Scholar] [CrossRef]
  41. Quintans-Júnior, L.J.; Almeida, J.R.G.S.; Lima, J.T.; Nunes, X.P.; Siqueira, J.S.; Oliveira, L.E.G.; Almeida, R.N.; Athayde-Filho, P.F.; Barbosa-Filho, J.M. Plants with anticonvulsant properties-A review. Rev. Bras. Farmacogn. 2008, 18, 798–819. [Google Scholar] [CrossRef]
  42. Sousa, F.C.F.; Melo, C.T.V.; Citó, M.C.O.; Félix, F.H.C.; Vasconcelos, S.M.M.; Fonteles, M.M.F.; Barbosa-Filho, J.M.; Viana, G.S.B. Plantas medicinais e seus constituintes bioativos: Uma revisão da bioatividade e potenciais benefícios nos distúrbios da ansiedade em modelos animais. Rev. Bras. Farmacogn. 2008, 18, 642–654. [Google Scholar] [CrossRef]
  43. Ribeiro-Filho, J.; Falcão, H.S.; Batista, L.M.; Barbosa-Filho, J.M.; Piuvezam, M.R. Effects of plant extracts on HIV-1 protease. Curr. HIV Res. 2010, 8, 531–544. [Google Scholar] [CrossRef]
  44. Barbosa-Filho, J.M.; Alencar, A.A.; Nunes, X.P.; Tomaz, A.C.A.; Sena-Filho, J.G.; Athayde-Filho, P.F.; Silva, M.S.; Souza, M.F.V.; Cunha, E.V.L. Sources of alpha-, beta-, gamma-, delta- and epsilon-carotenes: A twentieth century review. Rev. Bras. Farmacogn. 2008, 18, 135–154. [Google Scholar] [CrossRef]
  45. Alves, J.S.; Castro, J.C.; Freire, M.O.; Cunha, E.V.L.; Barbosa-Filho, J.M.; Silva, M.S. Complete assignment of the 1H and 13C spectra of four triterpenes of the ursane, artane, lupane and friedelane groups. Magn. Reson. Chem. 2000, 38, 201–206. [Google Scholar] [CrossRef]
  46. Sena-Filho, J.G.; Duringer, J.M.; Maia, G.L.A.; Tavares, J.F.; Xavier, H.S.; Silva, M.S.; Cunha, E.V.L.; Barbosa-Filho, J.M. Ecdysteroids from Vitex species: Distribution and compilation of their 13C-NMR spectral data. Chem. Biodivers. 2008, 5, 707–713. [Google Scholar] [CrossRef]
  47. Oliveira, S.L.; Silva, M.S.; Tavares, J.F.; Sena-Filho, J.G.; Lucena, H.F.S.; Romero, M.A.V.; Barbosa-Filho, J.M. Tropane alkaloids from genus Erythroxylum: Distribution and compilation of 13C-NMR spectral data. Chem. Biodivers. 2010, 7, 302–326. [Google Scholar] [CrossRef]
  48. Vasconcelos, S.M.M.; Honório-Júnior, J.E.R.; Abreu, R.N.D.C.; Silva, M.C.C.; Barbosa-Filho, J.M.; Lobato, R.F.G. Pharmacologic Study of Some Plant Species from the Brazilian Northeast: Calotropis procera, Agava sisalana, Solanum paludosum, Dioscorea cayenensis and Crotalaria retusa. In Medicinal Plants: Classification, Biosynthesis and Pharmacology; Varela, A., Jasiah Ibañez, J., Eds.; Nova Science Publishers, Inc.: Hauppauge, NY, USA, 2009; Volume 4, pp. 189–202. [Google Scholar]
  49. Vasconcelos, S.M.M.; Pereira, E.C.; Chaves, E.M.C.; Lobato, R.F.G.; Barbosa-Filho, J.M.; Patrocínio, M.C.A. Pharmacologic Study of Amburana cearensis and Aniba Genus. In Recent Progress in Medicinal Plants. Drug Plant IV; Singh, V.K., Govil, J.N., Eds.; Studium Press LLC: Houston, TX, USA, 2010; Volume 30, pp. 51–64. [Google Scholar]
  50. Almeida, C.L.F.; Falcão, H.S.; Lima, G.R.M.; Montenegro, C.A.; Lira, N.S.; Athayde-Filho, P.F.; Rodrigues, L.C.; Souza, M.F.V.; Barbosa-Filho, J.M.; Batista, L.M. Bioactivities from marine algae of the genus Gracilaria. Int. J. Mol. Sci. 2011, 12, 4550–4573. [Google Scholar]
  51. Barbosa-Filho, J.M.; Sette, I.M.F.; Cunha, E.V.L.; Guedes, D.N.; Silva, M.S. Protoberberine Alkaloids. In The Alkaloids; Cordell, G.A., Ed.; Elsevier: Amsterdam, The Netherlands, 2005; Volume 62, pp. 1–75. [Google Scholar]
  52. Conserva, L.M.; Pereira, C.A.B.; Barbosa-Filho, J.M. Alkaloids of the Hernandiaceae: Occurrence and a Compilation of Their Biological Activities. In The Alkaloids; Cordell, G.A., Ed.; Elsevier: Amsterdam, The Netherlands, 2005; Volume 62, pp. 175–243. [Google Scholar]
  53. Barbosa-Filho, J.M.; Piuvezam, M.R.; Moura, M.D.; Silva, M.S.; Lima, K.V.B.; da Cunha, E.V.L.; Fechine, I.M.; Takemura, O.S. Anti-inflammatory activity of alkaloids: A twenty-century review. Rev. Bras. Farmacogn. 2006, 16, 109–139. [Google Scholar] [CrossRef]
  54. Yoo, K.Y.; Hwang, I.K.; Kim, J.D.; Kang, I.J.; Park, J.; Yi, J.S.; Kim, J.K.; Bae, Y.S.; Won, M.H. Anti-inflammatory effect of the ethanol extract of Berberis koreana in a gerbil model of cerebral ischemia/reperfusion. Phytother. Res. 2008, 22, 1527–1532. [Google Scholar] [CrossRef]
  55. Kuo, C.L.; Chi, C.W.; Liu, T.Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004, 203, 127–137. [Google Scholar] [CrossRef]
  56. Bezerra-Santos, C.R.; Vieira-de-Abreu, A.; Barbosa-Filho, J.M.; Bandeira-Melo, C.; Piuvezam, M.R.; Bozza, P.T. Anti-allergic properties of Cissampelos sympodialis and its isolated alkaloid warifteine. Int. Immunopharmacol. 2006, 6, 1152–1160. [Google Scholar] [CrossRef]
  57. Costa, H.F.; Bezerra-Santos, C.R.; Barbosa Filho, J.M.; Martins, M.A.; Piuvezam, M.R. Warifteine, a bisbenzylisoquinoline alkaloid, decreases immediate allergic and thermal hyperalgesic reactions in sensitized animals. Int. Immunopharmacol. 2008, 8, 519–525. [Google Scholar] [CrossRef]
  58. Kupeli, E.; Kosar, M.; Yesilada, E.; Baser, K.H.C; Baser, C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of turkish berberis species. Life Sci. 2002, 72, 645–657. [Google Scholar] [CrossRef]
  59. Ao, C.W.; Araki, N.; Tawata, S. Cyclooxygenase inhibitory compounds with antioxidant activities from Sophora subprostrata. Asian J. Chem. 2009, 21, 745–754. [Google Scholar]
  60. Yin, W.; Wang, T.S.; Yin, F.Z.; Cai, B.C. Analgesic and anti-inflammatory properties of brucine and brucine-N-oxide extracted from seeds of Strychnos nuxvomica. J. Ethnopharmacol. 2003, 88, 205–214. [Google Scholar] [CrossRef]
  61. Souza, E.T.; Lira, D.P.; Queiroz, A.C.; Silva, D.J.C.; Aquino, A.B.; Mella, E.A.C.; Lorenzo, V.P.; Miranda, G.E.C.; Araújo-Júnior, J.X.; Chaves, M.C.O.; et al. The antinociceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid isolated from seaweed of the genus Caulerpa. Mar. Drugs 2009, 7, 689–704. [Google Scholar] [CrossRef]
  62. Alarif, W.M.; Abou-Elnaga, Z.S.; Ayyad, S.E.N.; Al-Lihaibi, S.S. Insecticidal metabolites from the green alga Caulerpa racemosa. Clean-Soil Air Water 2010, 38, 548–557. [Google Scholar] [CrossRef]
  63. Liu, Y.; Morgan, J.B.; Coothankandaswamy, V.; Liu, R.; Jekabson, M.B.; Mahdi, F.; Nagle, D.G.; Zhou, Y.D. The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration. J. Nat. Prod. 2009, 72, 2104–2109. [Google Scholar]
  64. Ayyad, S.E.N.; Badria, F.A. Caulerpine: An antitumor indole alkaloid from Caulerpa racemosa. Alex. J. Pharm. Sci. 1994, 8, 217–219. [Google Scholar]
  65. Leite, C.P.; Araújo, F.L.O.; Melo, C.T.V.; Gutierrez, S.J.C.; Barbosa-Filho, J.M.; Sousa, F.C.F. Anti-inflammatory activity of riparin I (O-methyl-N-benzoyl tyramine) on paw edema models in mice. Inflamm. Res. 2011, 60, 202. [Google Scholar]
  66. Sousa, F.C.F.; Carvalho, A.M.R.; Leite, C.P.; Rocha, N.F.M.; Rios, E.R.V.; Vasconcelos, L.F.; Melo, C.T.V.; Lima, S.T.; Barbosa-Filho, J.M.; Vasconcelos, S.M.M. Anti-inflammatory activity of riparin II (N-2-hydroxybenzoyl tyramine) in rats. Inflammat. Res. 2011, 60, 206. [Google Scholar]
  67. Chen, J.J.; Chung, C.Y.; Hwang, T.L.; Chen, J.F. Amides and benzenoids from Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and elastase release by neutrophils. J. Nat. Prod. 2009, 72, 107–111. [Google Scholar] [CrossRef]
  68. Duwiejua, M.; Woode, E.; Obiri, D.D. Pseudo-akuammigine, an alkaloid from Picralima nitida seeds, has anti-inflammatory and analgesic actions in rats. J. Ethnopharmacol. 2002, 81, 73–79. [Google Scholar] [CrossRef]
  69. Zhou, H.; Mineshita, S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J. Pharm. Exp. Ther. 2000, 294, 822–829. [Google Scholar]
  70. Yesilada, E.; Kupeli, E. Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats. J. Ethnopharmacol. 2002, 79, 237–248. [Google Scholar] [CrossRef]
  71. Shen, Y.B.; Piao, X.S; Kim, S.W.; Wang, L.; Liu, P. The effects of berberine on the magnitude of the acute inflammatory response induced by Escherichia coli lipopolysaccharide in broiler chickens. Poult. Sci. 2010, 89, 13–19. [Google Scholar] [CrossRef]
  72. Das, S.K.; Ramakrishnan, S.; Mishra, K.; Srivastava, R.; Agarwal, G.G.; Singh, R.; Sircar, A.R. A randomized controlled trial to evaluate the slow acting symptom-modifying effects of colchicine in osteoarthritis of the knee: A preliminary report. Arthritis Care Res. 2002, 47, 280–284. [Google Scholar] [CrossRef]
  73. Idowu, T.O.; Iwalewa, E.O.; Aderogba, M.A.; Akinpelu, B.A.; Ogundaini, A.O. Antinociceptive, anti-inflammatory and antioxidant activities of eleagnine: An alkaloid isolated from Chrysophyllum albidum seed cotyledons. J. Biol. Sci. 2006, 6, 1029–1034. [Google Scholar] [CrossRef]
  74. Lal, B.; Bhise, N.B.; Gidwani, R.M.; Lakdawala, A.D.; Kalpana, J.; Patvardhan, S. Isolation, synthesis and biological activity of evolitrine and analogs. ARKIVOC 2005, 11, 77–97. [Google Scholar]
  75. Choi, H.S.; Kim, H.S.; Min, K.R.; Kim, Y.S.; Lim, H.K.; Chang, Y.K.; Chung, M.W. Anti-inflamamtory effects of fangchinoline and tetrandrine. J. Ethnopharmacol. 2000, 69, 173–179. [Google Scholar] [CrossRef]
  76. Shen, Y.C.; Chou, C.J.; Chiou, W.F.; Chen, C.F. Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: Comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol. Pharmacol. 2001, 60, 1083–1090. [Google Scholar]
  77. Manga, H.M.; Haddad, M.; Pieters, L.; Baccelli, C.; Penge, A.; Leclercq, J.Q. Anti-inflammatory compounds from leaves and root bark of Alchornea cordifolia (Schumach. & Thonn.) Müll. Arg. J. Ethnopharmacol. 2008, 115, 25–29. [Google Scholar] [CrossRef]
  78. Chen, J.J.; Luo, Y.T.; Hwang, T.L.; Sung, P.J.; Wang, T.C.; Chen, I.S. A new indole alkaloid and anti-inflammatory constituents from Strychnos cathayensis. Chem. Biodivers. 2008, 5, 1345–1352. [Google Scholar] [CrossRef]
  79. Ho, Y.L.; Tsai, H.Y.; Chang, Y.S. Studies on the antinociceptive and antiinflammatory effects of indigo and indirubin in mice. J. Chin. Med. Sci. 2001, 2, 263–271. [Google Scholar]
  80. Yousaf, M.; Hammond, N.L.; Peng, J.N.; Wahyuono, S.; McIntosh, K.A.; Charman, W.N.; Mayer, A.M.S.; Hamann, M.T. New manzamine alkaloids from an indo-pacific sponge. pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. J. Med. Chem. 2004, 47, 157–160. [Google Scholar]
  81. Peng, Z.; Zhang, Z.X.; Xu, Y.J. Effect of ligustrazine on CD11c and CD14 content on alveolar macrophages from patients with chronic bronchitis. Zhongguo Yaolixue Yu Dulixue Zazhi 2000, 14, 157–160. [Google Scholar]
  82. Fan, Z.; Liu, Y. Anti-inflammatory effects of tetramethylpyrazine. Shenyang Yaoke Daxue Xuebao 2000, 17, 289–291. [Google Scholar]
  83. Luo, Y.; Liu, M.; Xia, Y.; Dai, Y.; Chou, G.; Wang, Z. Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice. Phytomedicine 2010, 17, 726–731. [Google Scholar] [CrossRef]
  84. Rho, J.R.; Jun, C.S.; Ha, Y.A.; Yoo, M.J.; Cui, M.X.; Baek, H.S.; Lim, J.A.; Lee, Y.H.; Chai, K.Y. Isolation and characterization of a new alkaloid from seed of Prunus persica L. and its anti-inflammatory activity. Bull. Korean Chem. Soc. 2007, 28, 1289–1293. [Google Scholar] [CrossRef]
  85. Shang, J.H.; Cai, X.H.; Feng, T.; Zhao, Y.L.; Wang, J.K.; Zhang, L.Y.; Yan, M.; Luo, X.D. Pharmacological evaluation of Alstonia scholaris: Anti-inflammatory and analgesic effects. J. Ethnopharmacol. 2010, 129, 174–181. [Google Scholar] [CrossRef]
  86. Daware, M.B.; Mujumdar, A.M.; Ghaskabdi, S. Reproductive toxicity of piperine in swiss albino mice. Planta Med. 2000, 66, 231–236. [Google Scholar] [CrossRef]
  87. Williamson, L.; Illingworth, H.; Smith, D.; Mowat, A. Oral quinine in ankylosing spondylitis: A randomized placebo controlled double blind crossover trial. J. Rheumatol. 2000, 27, 2054–2055. [Google Scholar]
  88. Araújo, F.L.O.; Melo, C.T.V.; Rocha, N.F.M.; Moura, B.A.; Leite, C.P.; Amaral, J.F.; Barbosa-Filho, J.M.; Gutierrez, S.J.C.; Vasconcelos, S.M.M.; Viana, G.S.B.; et al. Antinociceptive effects of (O-methyl)-N-benzoyl tyramine (riparin I) from Aniba riparia (Nees) Mez (Lauraceae) in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 380, 337–344. [Google Scholar] [CrossRef]
  89. Stevenson, C.S.; Capper, E.A.; Roshak, A.K.; Marquez, B.; Grace, K.; Gerwick, W.H.; Jacobs, R.S.; Marshall, L.A. Scytonemin – a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm. Res. 2002, 51, 112–114. [Google Scholar] [CrossRef]
  90. Liu, X.L.; Chen, G.X.; Li, X.J.; Huang, Q.C.; Liu, Q.P.; Chen, J.F. Inhibitive effects of sinomenine on inflammatory synovium in rats with arthritis induced by collagen II and its mechanism. Guangzhou Zhongyiyao Daxue Xuebao 2002, 19, 214–217. [Google Scholar]
  91. Garcia-Argaez, A.N.; Ramirez Apan, T.O.; Delgado, H.P.; Velazquez, G.; Martinez-Varquez, M. Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Planta Med. 2000, 66, 279–281. [Google Scholar] [CrossRef]
  92. Xu, L.J.; Wei, S.C.; Lu, F.E.; Huang, G.; Huang, G.Y.; Ye, W.Y. Comparison of effects of several components derived from Strychnos nuxvomica on experimental arthritis. Tongji Yike Daxue Xuebao 2001, 30, 564–565. [Google Scholar]
  93. Shaheen, F.; Ahmad, M.; Khan, T.H.; Jalil, S.; Ejaz, A.; Sultankhodjaev, M.N.; Arfan, M.; Choudhary, M.I.; Rahman, A.U. Alkaloids of Aconitum laeve and their anti-inflammatory, antioxidant and tyrosinase inhibition activities. Phytochemistry 2005, 66, 935–940. [Google Scholar]
  94. Wang, Y.; Yang, X.; Zheng, X.; Li, J.; Ye, C.; Song, X. Theacrine, a purine alkaloid with anti-inflammatory and analgesic activities. Fitoterapia 2010, 81, 627–631. [Google Scholar] [CrossRef]
  95. Naidoo, D.; Coombes, P.H.; Mulholland, D.A.; Crouch, N.R.; van Den Bergh, A.J.J. N-Substituted acridone alkaloids from Toddaliopsis bremekampii (Rutaceae: Toddialoideae) of South-Central Africa. Phytochemistry 2005, 66, 1724–1728. [Google Scholar]

Share and Cite

MDPI and ACS Style

Souto, A.L.; Tavares, J.F.; Da Silva, M.S.; Diniz, M.d.F.F.M.; De Athayde-Filho, P.F.; Barbosa Filho, J.M. Anti-Inflammatory Activity of Alkaloids: An Update from 2000 to 2010. Molecules 2011, 16, 8515-8534. https://doi.org/10.3390/molecules16108515

AMA Style

Souto AL, Tavares JF, Da Silva MS, Diniz MdFFM, De Athayde-Filho PF, Barbosa Filho JM. Anti-Inflammatory Activity of Alkaloids: An Update from 2000 to 2010. Molecules. 2011; 16(10):8515-8534. https://doi.org/10.3390/molecules16108515

Chicago/Turabian Style

Souto, Augusto Lopes, Josean Fechine Tavares, Marcelo Sobral Da Silva, Margareth de Fátima Formiga Melo Diniz, Petrônio Filgueiras De Athayde-Filho, and José Maria Barbosa Filho. 2011. "Anti-Inflammatory Activity of Alkaloids: An Update from 2000 to 2010" Molecules 16, no. 10: 8515-8534. https://doi.org/10.3390/molecules16108515

APA Style

Souto, A. L., Tavares, J. F., Da Silva, M. S., Diniz, M. d. F. F. M., De Athayde-Filho, P. F., & Barbosa Filho, J. M. (2011). Anti-Inflammatory Activity of Alkaloids: An Update from 2000 to 2010. Molecules, 16(10), 8515-8534. https://doi.org/10.3390/molecules16108515

Article Metrics

Back to TopTop